-+ 0.00%
-+ 0.00%
-+ 0.00%

BIONTECH SE - TRIAL WILL CONTINUE TO EVALUATE SECOND DUAL PRIMARY ENDPOINT OF OVERALL SURVIVAL

路透·10/13/2026 10:45:11

請登錄查看新聞詳情